Back to Search
EZMINA LALANI, D.O.
D.O.
Internal Medicine Physician
NPI: 1831407964IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
N7555(TX)
Education
OTHER
Class of 2009
Research & Publications (20)
Expression of hepatocyte growth factor and its receptor c-met, correlates with severity of pathological injury in experimental alcoholic liver disease.
PMID 15806303·Int J Mol Med·2005
7-preclinical
CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium.
PMID 19531562·Mol Cancer Res·2009
7-preclinical
Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer--a pilot study.
PMID 18714395·Neoplasia·2008
4-observational
Re: Research training for oral and maxillofacial surgery.
PMID 18280014·Br J Oral Maxillofac Surg·2008
8-other
Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer.
PMID 18422771·BJU Int·2008
3-trial
Therapy Insight: parenteral estrogen treatment for prostate cancer--a new dawn for an old therapy.
PMID 17019433·Nat Clin Pract Oncol·2006
6-review
Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure.
PMID 16964546·Dig Dis Sci·2006
8-other
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.
PMID 16530510·Gastroenterology·2006
8-other
p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo.
PMID 16880527·Mol Cell Biol·2006
7-preclinical
Changes in vascular flow after transdermal oestradiol therapy for prostate cancer: a mechanism for cardiovascular toxicity and benefit?
PMID 16469015·BJU Int·2006
8-other
The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines.
PMID 16595724·Reproduction·2006
8-other
Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism.
PMID 16006886·J Urol·2005
8-other
Trefoil factor 2 (TFF2) deficiency in murine digestive tract influences the immune system.
PMID 16121031·Cell Physiol Biochem·2005
7-preclinical
The expression pattern of MUC1 glycoforms and other biomarkers of endometrial receptivity in fertile and infertile women.
PMID 15971251·Mol Reprod Dev·2005
8-other
Re: osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy.
PMID 15821605·J Urol·2005
8-other
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.
PMID 16317692·Hepatology·2005
4-observational
Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor kappaB and C/EBPbeta.
PMID 15177881·Peptides·2004
8-other
TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell lines.
PMID 15177882·Peptides·2004
8-other
Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
PMID 15360048·Acta Oncol·2004
7-preclinical
Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer.
PMID 15538232·J Urol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1111 OLIVE ST
MONTGOMERY, AL 36106 - Phone
- (334) 293-8888
Quick Facts
- NPI
- 1831407964
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile